References
- 1. Megherbi, S. E., Milan, C., Minier, D., Couvreur, G., Osseby, G. V., Tilling, K., ... & Giroud, M. (2003). Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke, 34 (3), 688-694.10.1161/01.STR.0000057975.15221.40
- 2. Suslina, Z. A., Piradov, M. A., & Domashenko, M. A. (2014). Stroke: the review of the problem (15 years later). Zhurnal Neurologists and Psychiatric Hymns SS Korsakova, 114 (11), 5-13.
- 3. Lieber, B. A., Taylor, B., Appelboom, G., Prasad, K., Bruce, S., Yang, A., ... & Connolly Jr, E. S. (2015). Meta-analysis of telemonitoring to improve HbA1c levels: promise for stroke survivors. Journal of Clinical Neuroscience, 22 (5), 807-811.10.1016/j.jocn.2014.11.009
- 4. Gentile, N. T., Seftchick, M. W., Huynh, T., Kruus, L. K., & Gaughan, J. (2006). Decreased mortality by normalizing blood glucose after acute ischemic stroke. Academic emergency medicine, 13 (2), 174-180.10.1197/j.aem.2005.08.009
- 5. Williams, L. S., Rotich, J., Qi, R., Fineberg, N., Spain, A., Bruno, A., ... & Tierney, W. R. (2002). Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology, 59 (1), 67-71.10.1212/WNL.59.1.67
- 6. Kohler, H. P. (2002). Insulin resistance syndrome: interaction with coagulation and fibrinolysis. Swiss medical weekly, 132 (19-20), 241-252.
- 7. Marques-Vidal, P., Mazoyer, E., Bongard, V., Gourdy, P., Ruidavets, J. B., Drouet, L., & Ferrières, J. (2002). Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care, 25 (8), 1371-1377.10.2337/diacare.25.8.1371
- 8. Arcaro, G., Cretti, A., Balzano, S., Lechi, A., Muggeo, M., Bonora, E., & Bonadonna, R. C. (2002). Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation, 105 (5), 576-582.10.1161/hc0502.103333
- 9. Imperatore, G., Riccardi, G., Iovine, C., Rivellese, A. A., & Vaccaro, O. (1998). Plasma fibrinogen: a new factor of the metabolic syndrome: a population-based study. Diabetes Care, 21 (4), 649-654.10.2337/diacare.21.4.649
- 10. Haapaniemi, E., Soinne, L., Syrjälä, M., Kaste, M., & Tatlisumak, T. (2004). Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke. Acta neurologica scandinavica, 110 (4), 242-247.10.1111/j.1600-0404.2004.00304.x
- 11. Berge, E., Friis, P., & Sandset, P. M. (2001). Hemostatic activation in acute ischemic stroke. Thrombosis research, 101 (2), 13-21.10.1016/S0049-3848(00)00380-7
- 12. Reeves, M. J., Vaidya, R. S., Fonarow, G. C., Liang, L., Smith, E. E., Matulonis, R., ... & Schwamm, L. H. (2010). Quality of care and outcomes in patients with diabetes hospitalized with ischemic stroke: findings from Get With the Guidelines – Stroke. Stroke, 41 (5), e409-e417.10.1161/STROKEAHA.109.57269320224058
- 13. Megherbi, S. E., Milan, C., Minier, D., Couvreur, G., Osseby, G. V., Tilling, K., ... & Giroud, M. (2003). Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke, 34 (3), 688-694.10.1161/01.STR.0000057975.15221.4012624292
- 14. Kiers, L., Davis, S. M., Larkins, R., Hopper, J., Tress, B., Rossiter, S. C., ... & Ratnaike, S. (1992). Stroke topography and outcome in relation to hyperglycaemia and diabetes. Journal of Neurology, Neurosurgery & Psychiatry, 55 (4), 263-270.10.1136/jnnp.55.4.2634890371583510
- 15. Anwar, M. M. U., Jahan, S. M. S., Afrin, S., & Hossain, M. Z. (2017). Diabetic and Non-diabetic Subjects with Ischemic Stroke: Risk Factors, Stroke Topography and Hospital Outcome. Journal of Medicine, 18 (2), 75-79.10.3329/jom.v18i2.33684
- 16. Jørgensen, H., Nakayama, H., Raaschou, H. O., & Olsen, T. S. (1994). Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke, 25 (10), 1977-1984.
- 17. Wu, S., Wang, C., Jia, Q., Liu, G., Hoff, K., Wang, X., ... & Liu, L. (2014). HbA1c is associated with increased all-cause mortality in the first year after acute ischemic stroke. Neurological research, 36 (5), 444-452.10.1179/1743132814Y.000000035524649851
- 18. Wu, S., Shi, Y., Wang, C., Jia, Q., Zhang, N., Zhao, X., ... & Investigators for the Survey on Abnormal Glucose Regulation in Patients With Acute Stroke Across China (ACROSS-China. (2013). Glycated hemoglobin independently predicts stroke recurrence within one year after acute first-ever non-cardioembolic strokes onset in a Chinese cohort study. PLoS One, 8 (11), e80690.10.1371/journal.pone.0080690382747324236195
- 19. Jing, J., Pan, Y., Zhao, X., Zheng, H., Jia, Q., Mi, D., ... & He, Y. (2017). Insulin resistance and prognosis of nondiabetic patients with ischemic stroke: the ACROSS-China study (abnormal glucose regulation in patients with acute stroke across China). Stroke, 48 (4), 887-893.10.1161/STROKEAHA.116.01561328235959
- 20. Roquer, J., Giralt-Steinhauer, E., Cerdà, G., Rodríguez-Campello, A., Cuadrado-Godia, E., Jiménez-Conde, J., ... & Ois, A. (2015 ). Glycated hemoglobin value combined with initial glucose levels for evaluating mortality risk in patients with ischemic stroke. Cerebrovascular diseases, 40 (5-6), 244-250.10.1159/00044073526484656